Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
10/2003
10/02/2003US20030186308 Prostacyclin-stimulating factor-2
10/02/2003US20030186304 Comprises protein for diagnosis and treatment of cardiovascular disorders
10/02/2003US20030186292 Methods for identifying DNA molecules that encode a natural product having bioactivity or encode a protein involved in the production of natural product having bioactivity
10/02/2003US20030186290 Gene involved in CADASIL, method of diagnosis and therapeutic application
10/02/2003US20030186281 Modified tetracycline repressor protein compositions and methods of use
10/02/2003US20030186275 Using bacterial peptides to develop vaccine to protect against mycobacterium infections
10/02/2003US20030186270 Compositions and methods for reverse transcription of nucleic acid molecules
10/02/2003US20030186269 Ssa-56 kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
10/02/2003US20030186264 Comprises enzymatic polypeptide for diagnosis and treatment of genetic disorders; drug screening; immunoassay; high throughput assay
10/02/2003US20030186258 Comprises protease (KEX1) for processing fusion proteins containing peptides or proteins of industrial and/or therapeutic interest; biocatalysts
10/02/2003US20030186253 Fibroblast growth factor-13
10/02/2003US20030186238 RNA detection assays
10/02/2003US20030186232 Human and non-human primate homologues of Nkd protein, nucleic acid sequences encoding, and uses thereof
10/02/2003US20030186229 Emission ratiometric indicators of phosphorylation
10/02/2003US20030185956 Separating aqueous mixture from a water-immiscible hydrophobic phase with a hydrophilic membrane; desired components move out through the membrane and into the hydrophobic phase; foods and cosmetics
10/02/2003US20030185935 Method for producing breads
10/02/2003US20030185852 Parasitic protozoan isolate
10/02/2003US20030185849 React with convalescent phase antiserum from an E. canis-infected dog; useful in the development of vaccines and serodiagnostics
10/02/2003US20030185848 Using such isolated antigens for producing immune responses in bovines or other non-human animals.
10/02/2003US20030185842 Heat shock protein-based vaccines and immunotherapies
10/02/2003US20030185830 Compositions and methods for the therapy and diagnosis of prostate cancer
10/02/2003US20030185828 For treating osteoarthritis
10/02/2003US20030185819 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation.
10/02/2003US20030185815 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/02/2003US20030185803 Autologous bone graft material
10/02/2003US20030185802 DNA construct operably encoding a vascular endothelial growth factor receptor protein.
10/02/2003US20030185800 Human interferon-epsilon: a type I interferon
10/02/2003CA2517582A1 Saccharomyces cerevisiae yeast strain with improved phytase activity
10/02/2003CA2482349A1 Process for preparing conjugated linoleic acid
10/02/2003CA2480099A1 Erbb3 based methods and compositions for treating neoplasms
10/02/2003CA2479732A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/02/2003CA2479731A1 Novel compositions and methods in cancer associated with altered expression of tbx21
10/02/2003CA2479730A1 Novel compositions and methods in cancer
10/02/2003CA2479727A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
10/02/2003CA2479723A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
10/02/2003CA2479721A1 Novel compositions and methods in cancer associated with altered expression of prlr
10/02/2003CA2479719A1 Novel compositions and methods in cancer associated with altered expression of mcm3ap
10/02/2003CA2479530A1 Hiv therapeutic
10/02/2003CA2479158A1 Recombinant expression vectors for functional nav1.9 sodium channels
10/02/2003CA2478113A1 Modified promoter capable of functioning in a filamentous fungus
10/02/2003CA2478063A1 Lymphatic and blood endothelial cell genes
10/01/2003EP1348766A1 Method and kit for detecting membrane protein-protein interactions
10/01/2003EP1348760A2 Production of inactive mutants or mutants with a low activity of an alkaline phosphatase and their expression in yeast
10/01/2003EP1348759A1 Mutated penicillin expandase and process for preparing 7-ADCA using the same
10/01/2003EP1348715A2 CD19xCD3 specific polypeptides and uses thereof
10/01/2003EP1348453A1 Autologous bone graft material
10/01/2003EP1348036A2 Protection against mycobacterial infections
10/01/2003EP1348027A2 Gene disruption methodologies for drug target discovery
10/01/2003EP1348025A2 Enzymatic deprotection of amines and hydroxides
10/01/2003EP1348022A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/01/2003EP1348018A1 Culture medium for detecting bacteria of listeria genus
10/01/2003EP1347992A2 Polymorphic bone morphogenetic protein 2
10/01/2003EP1347770A2 Method of making a protein polymer and uses of the polymer
10/01/2003EP1347730A2 Recombinant anti-cd30 antibodies and uses thereof
10/01/2003EP1148785B1 Pesticidal use of a parasitic flagellate for eliminating or suppressing harmful algae blooms
10/01/2003EP0726946B1 METHOD FOR SIMULTANEOUS IDENTIFICATION OF DIFFERENTIALLY EXPRESSED mRNAs AND MEASUREMENT OF RELATIVE CONCENTRATIONS
10/01/2003EP0662087B1 Method for purifying retinal pigmented epithelium derived neurotrophic factor
10/01/2003EP0594678B1 Production of polyalkanoate
10/01/2003CN1446260A Lipoxygenase genes, promoters, transit peptides and protein thereof
10/01/2003CN1446259A Nucleotide sequences which code for lysR2 gene
10/01/2003CN1446228A 校正基因 Correction gene
10/01/2003CN1446227A Novel fibroblast growth factor (FRF23) and method for use
10/01/2003CN1446226A New nucleotide equences coding for lysR1 gene
10/01/2003CN1446103A Treating endotoxemia and related disorders with probiotics
10/01/2003CN1446095A Animal papilla disinfectants and method for improving microbial environment which harmful to animal
10/01/2003CN1446053A Food supplement
10/01/2003CN1445365A Method for preparing algin lyase and its application
10/01/2003CN1445362A Method for increasing yield of superoxide dismutase of radioresistant coccus by radiation induction
10/01/2003CN1445361A Gordona nitida and application of removing sulfur element from sulfur compound
10/01/2003CN1445360A Method of artificial planting northerly Chinese caterpillar fungus for increasing content of physiologically active substance
10/01/2003CN1445359A Technique for artificial breeding Chinese caterpillar fungus with out polypide
09/2003
09/30/2003US6627798 Nucleotide sequences coding polypeptide associated with tyrosine biosynthesis for use in generation of amplified tyrosine concentration in plants
09/30/2003US6627747 Essential bacterial genes and their use
09/30/2003US6627744 Synthesis of glycodendrimer reagents
09/30/2003US6627741 Isolated antibody or fragment thereof that specifically binds to a protein with a specified amino acid sequence, as well as a hybridoma encoding it
09/30/2003US6627739 Antibodies having preferential binding to proteases; screening for enzyme inhibitors used in therapy of neurodegenerative diseases, such as Alzheimer's disease
09/30/2003US6627728 BASB010 polypeptides; fusion proteins; use in vaccines against bacterial infections including otitis media; related by sequence homology to TlyC hemolysin protein of Serpulina hyodysenteriae
09/30/2003US6627605 Polynucleotides which encode them, and methods for their use. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention further provides methods for diagnosing or treating disorders with
09/30/2003US6627449 Fluorescent protein sensors for measuring the pH of a biological sample
09/30/2003US6627442 Methods for stable transduction of cells with hiv-derived viral vectors
09/30/2003US6627438 Nucleotide sequences for use in the generation of amidated peptides
09/30/2003US6627430 Cultivation of zygomycetes from spent sulfite liquor
09/30/2003US6627427 Recombinant Saccharopolyspora erythraea cell; expression vector for given gene from Streptomyces collinus or Streptomyces coelicolor; biosynthesis; useful for producing polyketides
09/30/2003US6627424 Protein comprising a sequence non-specific binding domain and a DNA polymerase domain; enhances binding and catalytic activity
09/30/2003US6627420 Process for the production of alanine by recombinant microorganisms
09/30/2003US6627415 Isolated nucleic acid comprising a nucleotide sequence encoding fibrinogen-like domain; use in diagnosis and treatment of tumor angiogenesis, wound healing, thromboembolic diseases, atherosclerosis and inflammationinflammation
09/30/2003US6627414 Genetic engineering; overlapping Dna sequences
09/30/2003US6627405 53BP2 complexes
09/30/2003US6627204 Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses
09/30/2003US6627186 Treating neutrophil disorders; granulocyte colony stimulating factor (G-CSF)
09/30/2003US6626546 Apparatus for using optical tweezers to manipulate materials
09/30/2003CA2168382C Method for the extraction of periplasmic proteins from prokaryotic microorganisms in the presence of arginine
09/25/2003WO2003078643A1 Metabolic engineering for improved xylose utilisation of saccharomyces cerevisiae
09/25/2003WO2003078642A1 Saccharomyces cerevisiae mutant
09/25/2003WO2003078638A1 Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms
09/25/2003WO2003078637A2 Optimizing glycan processing in plants
09/25/2003WO2003078635A1 Gene participating in acetic acid tolerance, acetic acid bacterium bred using the gene, and process for producing vinegar with the use of the acetic acid bacterium
09/25/2003WO2003078634A1 Novel carbonyl reductase, gene encoding it and process for producing optically active alcohols using the same
09/25/2003WO2003078633A1 POLYPEPTIDES BINDING TO HUMAN SYNTAXIN 1a
09/25/2003WO2003078632A1 Novel receptor polypeptides and polynucleotides encoding the same
1 ... 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 ... 1489